NO882615L - Legemiddelpreparat med findelte ebselen-krystaller. - Google Patents

Legemiddelpreparat med findelte ebselen-krystaller.

Info

Publication number
NO882615L
NO882615L NO88882615A NO882615A NO882615L NO 882615 L NO882615 L NO 882615L NO 88882615 A NO88882615 A NO 88882615A NO 882615 A NO882615 A NO 882615A NO 882615 L NO882615 L NO 882615L
Authority
NO
Norway
Prior art keywords
ebselen
pharmaceutical preparation
crystals
finally shared
ebselen crystals
Prior art date
Application number
NO88882615A
Other languages
English (en)
Other versions
NO175133B (no
NO175133C (no
NO882615D0 (no
Inventor
Axel Roemer
Juergen Seidel
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of NO882615D0 publication Critical patent/NO882615D0/no
Publication of NO882615L publication Critical patent/NO882615L/no
Publication of NO175133B publication Critical patent/NO175133B/no
Publication of NO175133C publication Critical patent/NO175133C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D293/00—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
    • C07D293/10—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D293/12—Selenazoles; Hydrogenated selenazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO882615A 1987-06-20 1988-06-14 Fremgangsmåte for fremstilling av et legemiddelpreparat med findelte 2-fenyl-1,2-benzisoselenazol-3(2H)-on NO175133C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873720493 DE3720493A1 (de) 1987-06-20 1987-06-20 Arzneizubereitungen mit mikronisierten ebselen-kristallen

Publications (4)

Publication Number Publication Date
NO882615D0 NO882615D0 (no) 1988-06-14
NO882615L true NO882615L (no) 1988-12-21
NO175133B NO175133B (no) 1994-05-30
NO175133C NO175133C (no) 1994-09-07

Family

ID=6330016

Family Applications (1)

Application Number Title Priority Date Filing Date
NO882615A NO175133C (no) 1987-06-20 1988-06-14 Fremgangsmåte for fremstilling av et legemiddelpreparat med findelte 2-fenyl-1,2-benzisoselenazol-3(2H)-on

Country Status (25)

Country Link
US (1) US5021242A (no)
EP (1) EP0296389B1 (no)
JP (1) JPH0713016B2 (no)
KR (1) KR970005322B1 (no)
AT (1) ATE69165T1 (no)
AU (1) AU603454B2 (no)
CA (1) CA1310906C (no)
DD (1) DD271056A5 (no)
DE (2) DE3720493A1 (no)
DK (1) DK173628B1 (no)
ES (1) ES2041736T3 (no)
FI (1) FI88256C (no)
GE (1) GEP19960342B (no)
GR (1) GR3003084T3 (no)
HU (1) HU200096B (no)
IE (1) IE63512B1 (no)
LT (1) LT3669B (no)
LV (1) LV10381B (no)
MX (1) MX169170B (no)
NO (1) NO175133C (no)
NZ (1) NZ225066A (no)
PT (1) PT87767B (no)
RU (1) RU1834657C (no)
UA (1) UA12648A (no)
ZA (1) ZA884025B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5368864A (en) * 1988-11-25 1994-11-29 Henning Berlin Gmbh Chemie- Und Pharmawerk Formulation of oxypurinol and/or its alkali and alkaline earth salts
FR2684298B1 (fr) * 1991-12-03 1994-03-11 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
JP2553434B2 (ja) * 1992-04-28 1996-11-13 第一製薬株式会社 粒状製剤
RU2143898C1 (ru) * 1993-10-27 2000-01-10 Дайити Фармасьютикал Ко., Лтд. Гранулированный фармацевтический препарат и водная суспензия на его основе
US5609883A (en) * 1994-09-16 1997-03-11 Advanced Technology Pharmaceuticals Corporation Compressed tablet transitory lubricant system
US5618845A (en) 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
EP0812195B1 (en) * 1995-02-28 2002-10-30 Aventis Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol compounds
NZ501248A (en) * 1997-08-26 2001-06-29 Aventis Pharma Inc Pharmaceutical composition for combination of piperidinoalkanol-decongestant
US6242473B1 (en) * 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
CA2368484A1 (en) 1999-03-31 2000-10-05 Daiichi Pharmaceutical Co., Ltd. Substrates for thioredoxin reductase
AU4239302A (en) * 2001-06-28 2003-01-02 Pfizer Products Inc. Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
JP2006518754A (ja) * 2003-02-24 2006-08-17 マリンクロッド・インコーポレイテッド ベンズヒドリルチオアセトアミドの改良製法
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
US20080293777A1 (en) * 2007-05-23 2008-11-27 Erlanson Daniel A Weight Loss Treatment
GB201102248D0 (en) 2011-02-09 2011-03-23 Isis Innovation Treatment of bipolar disorder
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
TW201613888A (en) 2014-09-26 2016-04-16 Helsinn Healthcare Sa Crystalline forms of an NK-1 antagonist
WO2022167778A1 (en) * 2021-02-02 2022-08-11 Haiku Therapeutics Ltd Ebselen as adenosine receptor modulator
WO2023240092A1 (en) * 2022-06-06 2023-12-14 Sound Pharmaceuticals Inc. Ebselen containing oral dosage forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3027073C2 (de) * 1980-07-17 1985-03-07 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische Präparate, enthaltend 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
DE3407511A1 (de) * 1984-03-01 1985-09-05 A. Nattermann & Cie GmbH, 5000 Köln Benzisoselenazolthione, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3616923A1 (de) * 1986-05-20 1987-11-26 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
DE3620674A1 (de) * 1986-06-20 1987-12-23 Nattermann A & Cie Salbe zur behandlung von hauterkrankungen

Also Published As

Publication number Publication date
UA12648A (uk) 1997-02-28
KR970005322B1 (ko) 1997-04-15
AU603454B2 (en) 1990-11-15
DK333388A (da) 1988-12-21
GEP19960342B (en) 1996-02-20
DD271056A5 (de) 1989-08-23
NZ225066A (en) 1990-07-26
NO175133B (no) 1994-05-30
FI88256B (fi) 1993-01-15
JPH01100125A (ja) 1989-04-18
NO175133C (no) 1994-09-07
KR890000084A (ko) 1989-03-11
EP0296389A1 (de) 1988-12-28
EP0296389B1 (de) 1991-11-06
HUT50037A (en) 1989-12-28
ES2041736T3 (es) 1996-07-16
ATE69165T1 (de) 1991-11-15
IE63512B1 (en) 1995-05-03
PT87767B (pt) 1992-10-30
FI88256C (fi) 1993-04-26
CA1310906C (en) 1992-12-01
RU1834657C (ru) 1993-08-15
FI882912A (fi) 1988-12-21
DK333388D0 (da) 1988-06-17
IE881628L (en) 1988-12-20
ZA884025B (en) 1988-12-20
LT3669B (en) 1996-01-25
DE3866033D1 (de) 1991-12-12
JPH0713016B2 (ja) 1995-02-15
GR3003084T3 (en) 1993-02-17
PT87767A (pt) 1989-05-31
LTIP903A (en) 1995-03-27
HU200096B (en) 1990-04-28
NO882615D0 (no) 1988-06-14
LV10381B (en) 1995-06-20
DE3720493A1 (de) 1989-01-26
US5021242A (en) 1991-06-04
FI882912A0 (fi) 1988-06-17
LV10381A (lv) 1995-02-20
AU1811688A (en) 1988-12-22
MX169170B (es) 1993-06-23
DK173628B1 (da) 2001-05-07

Similar Documents

Publication Publication Date Title
NO882615L (no) Legemiddelpreparat med findelte ebselen-krystaller.
PT86819A (pt) Process for the preparation of novel insulin derivatives and of pharmaceutical compositions containing the same
FI863652A0 (fi) 7-isopropoxiisflavoninklusionskomplex bildat med cyklodextrin och ett foerfarande foer dess framstaellning.
SE8700499D0 (sv) Novel pharmacologically active compounds
DE3686483D1 (de) Arzneimittel.
NO821645L (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzoazepinderivater
NO883506D0 (no) Fremgangsmaate for fremstilling av foretrede polyoksyalkylenderivater.
IS1565B (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
DK324185A (da) 2-substituerede 1,3-propylidendiphosphonatderivater, deres fremstilling og farmaceutiske praeparater med indhold deraf
DK0598770T3 (da) Pyrazinderivater samt fremstilling og anvendelse deraf
ES2012339B3 (es) Preparacion oral de ajo y procedimiento para su fabricacion
PT87024A (pt) Process for the preparation of propiolophenone derivatives and of pharmaceutical compositions containing the same
PT87550A (pt) Process for the preparation of pyrimidine derivatives and of pharmaceutical compositions containing the same
AU530678B2 (en) Phosphono-hydroxy-acetic acid
NZ220800A (en) Tetrahydrobenzothiazoles and pharmaceutical compositions
NO874780D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-benzimidazol-derivater.
ATE12241T1 (de) Leukotrienaehnliche verbindungen, deren herstellung und verwendung in pharmazeutischen zusammensetzungen.
NO162239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-carbolin-3-carboxylsyrederivater.

Legal Events

Date Code Title Description
MK1K Patent expired